GGNBP2
Basic information
Region (hg38): 17:36544912-36589848
Previous symbols: [ "ZNF403" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GGNBP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 30 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 2 | 0 |
Variants in GGNBP2
This is a list of pathogenic ClinVar variants found in the GGNBP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-36545769-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
17-36545783-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
17-36545798-A-G | not specified | Uncertain significance (Mar 20, 2023) | ||
17-36554844-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
17-36554852-T-A | not specified | Uncertain significance (Feb 10, 2025) | ||
17-36554862-C-T | not specified | Uncertain significance (Feb 25, 2025) | ||
17-36557107-G-A | not specified | Uncertain significance (Jan 20, 2025) | ||
17-36557251-A-G | not specified | Uncertain significance (Jan 22, 2025) | ||
17-36557282-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
17-36557285-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
17-36557329-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
17-36560773-G-A | not specified | Likely benign (Dec 26, 2023) | ||
17-36567659-A-G | GGNBP2-related disorder | Benign (Nov 12, 2019) | ||
17-36567665-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
17-36567731-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
17-36578033-T-C | not specified | Uncertain significance (Nov 21, 2024) | ||
17-36578051-G-A | not specified | Uncertain significance (Dec 11, 2024) | ||
17-36578110-C-T | Developmental disorder | Uncertain significance (Aug 11, 2021) | ||
17-36578167-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
17-36578176-T-C | not specified | Uncertain significance (Oct 17, 2023) | ||
17-36579322-A-G | not specified | Uncertain significance (Apr 08, 2023) | ||
17-36581478-T-G | not specified | Uncertain significance (Sep 29, 2022) | ||
17-36581492-C-G | not specified | Uncertain significance (Jul 14, 2024) | ||
17-36581494-A-G | not specified | Likely benign (Aug 10, 2021) | ||
17-36581503-C-A | not specified | Uncertain significance (Jan 16, 2025) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: May be involved in spermatogenesis.;
Intolerance Scores
- loftool
- 0.157
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.47
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.673
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.166
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ggnbp2
- Phenotype
- embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; immune system phenotype; homeostasis/metabolism phenotype; skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- spermatogenesis;negative regulation of cell population proliferation;negative regulation of gene expression;cell differentiation;negative regulation of peptidyl-serine phosphorylation of STAT protein;negative regulation of tyrosine phosphorylation of STAT protein;labyrinthine layer blood vessel development;negative regulation of protein tyrosine kinase activity
- Cellular component
- nucleus;cytoplasm;cytoplasmic vesicle
- Molecular function